Skip to main content
. 2021 Feb 15;24(2):e25667. doi: 10.1002/jia2.25667

Table 3.

Comparison between MSM who attended the onsite screening and those who did not among MSM who had a preference of PrEP in China, 2019 (n = 1933)

Characteristics Total (N/%) MSM who attended the onsite screening (N/%) MSM who did not attend the onsite screening (N/%) χ2 p‐value
Total 1933 (100.0) 1212 (62.7) 721 (37.3)
Preference of PrEP
Daily PrEP 828 (42.8) 566 (46.7) 262 (36.3) 19.820 <0.001
On‐demand PrEP 1105 (57.2) 646 (53.3) 459 (63.7)
Age (years) (mean, quantiles) 29.0 (25.0, 36.0) 30.0 (25.0, 36.0) 28.0 (24.0, 35.0) <0.001
Education level
High school or below 451 (23.3) 247 (20.4) 204 (28.3) 15.830 <0.001
Graduate and above 1482 (76.7) 965 (79.6) 517 (71.7)
Monthly income (USD)
0 to 857 1125 (58.2) 642 (53.0) 483 (67.0) 36.526 <0.001
≥858 808 (41.8) 570 (47.0) 238 (33.0)
Marital status
Married with female 147 (7.6) 85 (7.0) 62 (8.6) 1.618 0.203
Single, in a relationship or habitat with male, separated, divorced with female or widowed 1786 (92.4) 1127 (93.0) 659 (91.4)
Have you been on Post‐exposure Prophylaxis in the past six months?
Yes 117 (6.1) 72 (5.9) 45 (6.2) 0.072 0.789
No 1816 (93.9) 1140 (94.1) 676 (93.8)
Number of male sexual partners in the past six months (mean, quantiles) 4.0 (2.0, 6.0) 4.0 (3.0, 6.0) 3.0 (2.0, 5.0) <0.001
Had CLAI in the past six months
Yes 1226 (63.4) 791 (65.3) 435 (60.3) 4.739 0.029
No 707 (36.6) 421 (34.7) 286 (39.7)
Have diagnosis of any STIs in the past six months a
Yes 240 (12.4) 159 (13.1) 81 (11.2) 1.476 0.224
No or don’t know 1693 (87.6) 1053 (86.9) 640 (88.8)
Recreational drug usage in the past six months b
Yes 793 (41.0) 523 (43.2) 270 (37.4) 6.079 0.014
No 1140 (59.0) 689 (56.8) 451 (62.6)
Subjective expected risk of HIV infection of self (as in 0% to 100%)
Very high risk (> 75%) 136 (7.0) 85 (7.0) 51 (7.1) 7.857 0.049
High risk (75% to 50%) 258 (13.3) 177 (14.6) 81 (11.2)
Median risk (49% to 25%) 609 (31.5) 393 (32.4) 216 (30.0)
Low and no risk (0% to 24%) 930 (48.1) 557 (46.0) 373 (51.7)

CLAI, condomless anal intercourse; MSM, men who have sex with men; PrEP, pre‐exposure prophylaxis; STIs, sexually transmitted infections.

a

STIs included syphilis, HSV‐2, gonorrhoea, chlamydia, chancroid, lymphogranuloma venereum and others

b

recreational drugs included alkyl nitrites, ecstasy, methamphetamine, amphetamine, tramadol, ketamine and others.